Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma
Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups
Better genetic diagnostics in Ugandan breast cancer patients
Sym015 shows superior specificity compared to TKIs for NSCLC
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic
Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer
COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours
Diagnosing, treating and managing breast cancer during COVID-19
COVID-19: Risk of millions relapsing back to smoking
A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer